Genetical and engineering biological drugs and non-biological targeted drugs in dermatology. Hobeish M.M.

The practical guidance presents modern recommendations (international and Russian) for the choice of therapy for patients with psoriasis, psoriatic arthritis, atopic dermatitis, urticaria, purulent (s barn) hydradenitis depending on the degree of severity, prevalence, localization, the presence of functional disorders and features The comorbide background, as well as indications, absolute and relative contraindications, necessary screening, monitoring and other issues of conducting dermatological patients using genetically engineering biological drugs and non-biological selective (targeted) agents.

also provides key information from relevant instructions approved in the Russian Federation by 2022, all genetically engineering biological and non-biological targeted drugs with the details of the features of their use. The publication is intended for dermatovenerals, rheumatologists, general practitioners, allergists and other specialists involved in the treatment of genetically engineering biological and non-biological targeted drugs. A practical guide can be used as a training manual for the training of doctors, clinical residents and interns in the system of postgraduate vocational education.